Population aging and the increasing prevalence of chronic diseases are catalyzing a fundamental transformation in public health systems. This shift is away ...
Results from the AZALEA-TIMI 71 phase 2 trial showed great promise for abelacimab to transform care for high-risk patients with atrial fibrillation.
Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...
Introduction Good health system governance is essential for reducing high mortality and morbidity after injury in low- and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback